$SUZ

Suzano S.A.

CIK:0000909327|SEC Filings

Consolidated statements of income (Loss) - BRL (R$) R$ in Thousands	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Profit (loss) [abstract]
NET SALES	R$ 50,115,679	R$ 47,403,282	R$ 39,755,575
Cost of sales	(33,889,504)	(27,401,527)	(25,076,675)
GROSS PROFIT	16,226,175	20,001,755	14,678,900
Operating Income (Expenses) [Abstract]
Selling expense	(3,312,740)	(2,938,547)	(2,596,377)
General and administrative expense	(2,790,154)	(2,619,844)	(1,923,228)
Loss from associates and joint ventures	(409,212)	(13,845)	(19,379)
Other operating income, net	934,940	1,261,573	2,076,372
Profit (loss) from operating activities	10,649,009	15,691,092	12,216,288
NET FINANCIAL INCOME (EXPENSES) [Abstract]
Finance costs	(6,883,755)	(5,541,903)	(4,659,162)
Finance income	1,766,626	1,737,434	1,825,649
Derivative gains, net	7,328,684	(9,112,683)	5,526,714
Foreign exchange gain (loss)	7,550,610	(15,884,993)	3,087,727
Profit (loss) before tax	20,411,174	(13,111,053)	17,997,216
Income and social contribution taxes [Abstract]
Current Tax Expense (Income) And Current Social Contribution Tax Expense (Income)	(518,379)	(1,365,599)	(395,392)
Adjustments for deferred tax expense	(6,455,108)	7,431,946	(3,495,443)
Profit (loss)	13,437,687	(7,044,706)	14,106,381
Profit (loss), attributable to [abstract]
Resulted of the year attributable to controlling shareholders'	13,408,189	(7,074,198)	14,084,848
Non-controlling interest	R$ 29,498	R$ 29,492	R$ 21,533
Earnings per share [abstract]
Basic earnings (loss) per share	R$ 10.84189	R$ (5.59313)	R$ 10.85794
Diluted earnings (loss) per share	R$ 10.81555	R$ (5.59313)	R$ 10.85387

Statement of cash flows, indirect method (Statement) - BRL (R$) R$ in Thousands	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Cash flows from (used in) operating activities
Net income (loss) for the year	R$ 13,437,687	R$ (7,044,706)	R$ 14,106,381
Adjustments to reconcile profit (loss)
Depreciation, depletion and amortization	10,913,290	8,874,931	6,999,839
Depreciation, right-of-use assets	383,968	349,064	321,271
Interest expense on lease liabilities	467,879	451,148	441,596
Result from sale and disposal of property, plant and equipment, intangible and biological assets, net	475,267	163,033	331,285
Income (expense) from associates and joint ventures	409,212	13,845	19,379
Exchange rate and monetary variations, net	(7,550,610)	15,884,993	(3,087,727)
Interest expenses on financing, loans and debentures	5,953,778	5,413,707	4,797,094
Adjustments for finance costs	(274,731)	(959,968)	(1,160,364)
Accrual of interest on marketable securities	(1,029,877)	(1,254,424)	(1,352,522)
Amortization of transaction costs, premium and discounts	101,926	80,099	67,353
Derivative financial instruments, net	(7,328,684)	9,112,683	(5,526,714)
Gain on fair value adjustments (Note 29)	(1,516,458)	(1,431,530)	(1,989,831)
Deferred income tax and social contribution	6,455,108	(7,431,946)	3,495,443
Interest on actuarial liabilities and cost of current service	79,287	75,850	69,231
Provision for judicial liabilities, net	(49,754)	138,318	139,934
Provision (reversal) for doubtful accounts, net	119,417	2,585	35,202
Provision (reversal) for inventory losses, net	141,635	77,353	31,419
Provision (reversal) for loss of ICMS credits, net	193,152	130,727	348,628
Premium expenses on early settlements	110,060
Other	92,622	69,535	66,938
Trade accounts receivable	1,586,613	(808,785)	2,155,448
Inventories	(216,357)	(863,648)	(48,673)
Recoverable taxes	(413,422)	(95,411)	(666,681)
Other assets	259,705	6,185	328,800
Trade accounts payable	6,630	2,164,832	463,003
Taxes payable	384,227	296,169	329,556
Payroll and charges	(91,499)	364,817	73,096
Other liabilities	(218,901)	(27,706)	(277,538)
Cash generated from operations	22,881,170	23,751,750	20,510,846
Payment of interest on financing, loans and debentures	(5,817,907)	(5,241,389)	(4,728,998)
Adjustment for operating costs	274,731	959,968	1,160,364
Premium expenses on early settlements paid	(110,060)
Interest received on marketable securities	1,213,789	1,500,437	681,268
Payment of income taxes	(289,548)	(366,339)	(308,002)
Cash provided by operating activities	18,152,175	20,604,427	17,315,478
Additions to property, plant and equipment	(4,578,826)	(9,190,589)	(11,674,183)
Additions to intangible	(82,492)	(162,042)	(104,931)
Purchase of biological assets	(7,913,483)	(7,180,450)	(5,777,952)
Proceeds from sales of property, plant and equipment and biological assets	122,729	167,983	183,576
Capital increase in affiliates	(21,979)	(41,281)	(48,462)
Marketable securities, net	2,941,921	205,954	(5,296,370)
Advances for acquisition of wood from operations with development and partnerships	(300,040)	(294,952)	(690,908)
Dividends received	8,835		44,789
Asset acquisition		(2,595,974)	(1,615,140)
Acquisition of subsidiaries			(1,060,718)
Acquisition of other investments	9,392	1,440,503
Net cash from acquisition of subsidiaries		19,113	5,002
Cash used in investing activities	(9,832,727)	(20,512,741)	(26,035,297)
Proceeds from loans, financing and debentures	23,871,760	15,692,905	10,944,794
Proceeds from derivative transactions	530,655	(550,581)	3,559,286
Payment of loans, financing and debentures	(22,353,325)	(9,410,807)	(4,296,447)
Payment of leases	(1,447,973)	(1,325,398)	(1,218,399)
Payment of interest on own capital and dividends	(2,208,158)	(1,624,653)	(192,532)
Liabilities for assets acquisitions and subsidiaries	(20,668)	(58,467)	(116,924)
Shares repurchased	(191,918)	(2,806,764)	(880,914)
Cash used by financing activities	(1,819,627)	(83,765)	7,798,864
EXCHANGE VARIATION ON CASH AND CASH EQUIVALENTS	(338,886)	665,026	(239,125)
Increase (Decrease) in cash and cash equivalents, net	6,499,821	7,921	(920,955)
At the beginning of the year	9,018,818	8,345,871	9,505,951
At the end of the year	R$ 15,179,753	R$ 9,018,818	R$ 8,345,871

Consolidated balance sheet - BRL (R$) R$ in Thousands	Dec. 31, 2025	Dec. 31, 2024
Current assets
Cash and cash equivalents	R$ 15,179,753	R$ 9,018,818
Marketable securities	9,932,774	12,971,547
Trade accounts receivable	6,560,607	9,132,860
Inventories	8,155,847	7,962,324
Recoverable taxes	887,085	929,001
Current Tax Assets Income Tax Related	659,202	180,618
Derivative financial instruments	1,556,978	1,006,427
Advances to suppliers	76,818	92,133
Other assets	858,005	889,232
Total current assets	43,867,069	42,182,960
Non-current assets
Marketable securities	319,680	391,964
Recoverable taxes	945,699	1,179,125
Deferred taxes	1,504,014	7,984,015
Derivative financial instruments	8,014,683	2,880,673
Advances to suppliers	2,788,262	2,503,537
Judicial deposits	418,301	487,993
Other assets	187,102	156,880
Biological assets	26,097,164	22,283,001
Investments accounted for using equity method	1,194,877	1,816,923
Property, plant and equipment	64,296,187	64,986,040
Right of use	5,331,789	5,180,691
Intangible	12,970,692	13,902,303
Total non-current assets	124,068,450	123,753,145
TOTAL ASSETS	167,935,519	165,936,105
Current liabilities
Trade accounts payable	5,141,386	6,033,285
Loans, financing and debentures	3,004,905	10,501,387
Lease liabilities	857,810	872,228
Derivative financial instruments	1,205,029	2,760,273
Taxes payable	240,010	245,353
Income taxes payable	218,238	118,362
Payroll and charges	1,132,713	1,232,971
Liabilities for assets acquisitions and subsidiaries	17,719	21,166
Dividends payable, non-cash assets distributions	1,393,121	2,200,917
Advances from customers	132,408	145,200
Other liabilities	429,532	346,796
Total current liabilities	13,772,871	24,477,938
Non-current liabilities
Loans, financing and debentures	91,796,352	90,934,144
Lease liabilities	6,072,080	6,100,687
Derivative financial instruments	8,136,320	7,694,547
Liabilities for assets acquisitions and subsidiaries	77,121	99,324
Provision for judicial liabilities	2,801,738	2,926,750
Employee benefit plans	741,143	721,560
Deferred taxes		12,596
Non-current provisions for employee benefits	332,322	361,974
Advances from customers	74,715	74,715
Other liabilities	178,684	116,295
Total non-current liabilities	110,210,475	109,042,592
TOTAL LIABILITIES	123,983,346	133,520,530
Equity
Share capital	24,235,546	19,235,546
Capital reserves	80,742	60,226
Treasury shares	(1,511,146)	(1,339,197)
Profit reserves	20,118,234	12,978,898
Accumulated other comprehensive income	888,669	1,348,796
Retained earnings
Controlling shareholders'	43,812,045	32,284,269
Non-controlling interest	140,128	131,306
Total equity	43,952,173	32,415,575
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY	R$ 167,935,519	R$ 165,936,105